Rituximab for linear immunoglobulin A bullous dermatosis. Dermatology Reports, [S. l.], v. 15, n. 2, 2022. DOI: 10.4081/dr.2023.9574. Disponível em: https://journals.pagepress.org/dr/article/view/9574. Acesso em: 19 jun. 2025.